Hypertension Therapy
Diabetic subsets have differential responses to antihypertensive treatment
Published in Obesity and Diabetes Week, January 26th, 2004
"Hypertension increases the renal and cardiovascular risks in diabetic patients," scientists in the Netherlands explained.
In their study, G. Laverman and colleagues at Martini Hospital in Groningen evaluated the "beneficial effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on renal and cardiovascular outcomes", with "a particular focus on their optimal use in the hypertensive diabetic patient with or without evidence of renal or cardiovascular disease."
"Although the mechanism of action of the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes Pathogenesis
Diabetes increases glucose uptake at proximal tubule brush border membrane - Body Composition
Skinfold measure better than BMI for body composition measure in adolescents - Breast Disease
Adolescent diet may be related to proliferative benign breast disease - Cancer Therapy
Endurance training can preserve fitness during chemotherapy+SCT - Cardiovascular Disease
Improved endothelial function may underlie cardioprotective effects of tea - Childhood Obesity
Obesity a problem among Hopi children - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
